Dosing Calculator

Online Prescription Assistance

NxRx®

Online Prescription and Ordering System

NxDocuments

Training and Resource Library

Nx2me® Clinician Portal

Flowsheets and Reporting

Find a Home Training Program Support Contact Us

For Healthcare Professionals

Home Hemodialysis Customer Support: 866-697-8243

Peritoneal Dialysis Customer Support: 800-323-5188

Talk to a Patient Consultant About Home Dialysis: 888-200-6456

Home Hemodialysis Customer Support: 866-697-8243

Peritoneal Dialysis Customer Support: 800-323-5188

Talk to a Patient Consultant About Home Dialysis: 888-200-6456

  • Home Hemodialysis
    • What You Need to Know About Kidney Disease
    • How Dialysis Frequency and Duration Impact Your Heart Health
    • Solo/Independent Home Dialysis
    • Nocturnal Home Dialysis
  • Peritoneal Dialysis
    • About Peritoneal Dialysis
  • Home Dialysis Systems
    • NxStage VersiHD with GuideMe Software
    • NxStage VersiHD
    • System One Portable Hemodialysis Machine
    • How Does System One Work?
    • Nx2me Connected Health
  • Travel and Lifestyle
    • Traveling with Home Hemodialysis
    • Traveling with Peritoneal Dialysis
    • Watch and Read Patient Stories
    • The Patient Journey
  • Home Dialysis Resources
    • The Benefits of More Frequent Home Dialysis
    • Talk to a Patient Consultant
    • Frequently Asked Questions
    • Visits with Vanessa Podcast
    • Webinars
    • Atlas: Stories & Resources for Living Well
    • Kidney Disease Resources and Links
    • Service and Support
    • Find A Center
  • Care Partner Support
    • Becoming a Care Partner for a Loved One on Hemodialysis
    • Support for Care Partners of Patients on Home Hemodialysis
    • Help for Family and Friends of Patients on Dialysis
    • Turn to Respite Care When You Need It
    • Valuable Support Networks
Find a Home Training Program Support Contact Us

For Healthcare Professionals

Home Hemodialysis Customer Support: 866-697-8243

Peritoneal Dialysis Customer Support: 800-323-5188

Talk to a Patient Consultant About Home Dialysis: 888-200-6456

Home Hemodialysis Customer Support: 866-697-8243

Peritoneal Dialysis Customer Support: 800-323-5188

Talk to a Patient Consultant About Home Dialysis: 888-200-6456

hero banner background

Patient Webinars

MythBusters Part 1: Home Dialysis Fact vs. Fiction

Are you considering home hemodialysis (HHD) but feeling overwhelmed with questions about self-cannulation, treating without a care partner, and traveling? Our Home Dialysis: Fact vs Fiction webinar series answers some of the most frequently asked questions about HHD, and debunks common myths about solo/independent home dialysis.

Sign up for our one-hour on-demand webinar to learn about:

  • Misconceptions about performing dialysis therapy at home
  • Tips on how to self-cannulate and overcome your fears
  • Associated lifestyle benefits of solo/independent home hemodialysis (HHD)
  • Traveling while on HHD
  • NxStage® machine portability

About

  • Myths and misconceptions about HHD
  • Solo/Independent Home Dialysis
  • Travel
  • Small Spaces and Machine Portability

Watch now
On-demand webinars are interactive and educational presentations focusing on important topics and issues in nephrology. Events are led by leading industry experts. Attendee participation and Q&A is an integral part of each presentation.

Speakers

Vanessa Evans

Director of Patient Advocacy and Communities

More Frequent HHD Patient

LaTasha

LaTasha Thomas

Patient Advocate and Peritoneal Dialysis Patient

Roshanda

Roshanda Turner

Patient Advocate and Solo HHD Patient

Dawn

Dawn Edwards

Patient Advocate and Solo HHD Patient

Risks and Responsibilities

Patients should review the following information carefully and discuss it with their doctors to decide whether home hemodialysis with NxStage systems is right for them.


Users should weigh the risks and benefits of performing home hemodialysis with NxStage systems.

  • Medical staff will not be present to respond to health emergencies that might happen during home treatments, including, among other things, dizziness, nausea, low blood pressure, and fluid or blood leaks.
  • Users may not experience the reported benefits of home, more frequent, or nocturnal hemodialysis with the NxStage systems.
  • The NxStage systems require a prescription for use.

 

 
Users will be responsible for all aspects of their hemodialysis treatment from start to finish.
 
  • Medical staff will not be present to perform home treatments. Users will be responsible for, among other things, equipment setup, needle insertions, responding to and resolving system alarms, system tear-down after treatment, monitoring blood pressure, ensuring proper aseptic technique is followed, and following all the training material and instructions that nurses provide.

 

Users will need additional resources to perform home hemodialysis.

  • Users will need a trained care partner to be present during your treatment at home (unless their doctor prescribes “solo/independent” home hemodialysis, described below).
  • Users must have a clean and safe environment for their home treatments.
  • Users will need space in their home for boxes of supplies necessary to perform home hemodialysis with NxStage systems.

 

Certain forms of home hemodialysis have additional risks.

  • If a doctor prescribes home hemodialysis more than 3 times a week, vascular access is exposed to more frequent use which may lead to access related complications, including infection of the site. Doctors should evaluate the medical necessity of more frequent treatments and discuss the risks and benefits of more frequent therapy with users.
  • If a doctor prescribes “solo/independent” home hemodialysis without a care partner during waking hours, risks of significant injury or death increase because no one is present to help users respond to health emergencies. If users experience needles coming out, blood loss, or very low blood pressure during solo/independent home hemodialysis, they may lose consciousness or become physically unable to correct the health emergency. Users will need additional ancillary devices and training to perform solo/independent home hemodialysis.
  • If a doctor prescribes “nocturnal” home hemodialysis at night while the user and a care partner are sleeping, risks increase due to the length of treatment time and because therapy is performed while the user and a care partner are sleeping. These risks include, among other things, blood access disconnects and blood loss during sleep, blood clotting due to slower blood flow or increased treatment time or both, and delayed response to alarms when waking from sleep. A doctor may need to adjust users’ medications for nocturnal home hemodialysis, including, among other things, iron, Erythropoiesis-Stimulating Agents (ESA), insulin/oral hypoglycemics, anticoagulants, and phosphate binders.

APM4458 Rev. B

Quick links

Careers

Risk and Responsibilities 

CA Supply Chain Act and UK Modern Slavery Act

Do Not Sell My Personal Information

Limit the Use of my Sensitive Personal Information

Consumer Health Data Privacy Statement 

Opt-Out of Sale

Opt-Out of Targeted Advertising

Opt-Out of Profiling

Our Offices

350 Merrimack Street
Lawrence, MA 01843
United States 

350 Merrimack Street
Lawrence, MA 01843
United States 

920 Winter Street
Waltham, MA 02451
United States

920 Winter Street
Waltham, MA 02451
United States

1-866-NxStage (697-8243)

1-866-NxStage (697-8243)

Contact

All Contact Information

All Contact Information

Social Media

Social Media

Facebook

X

Youtube

LinkedIn

© 2025 Fresenius Medical Care. All Rights Reserved.

© 2025 Fresenius Medical Care. All Rights Reserved.

Privacy Statement

Terms of Use

Cookie Settings

You are about to leave Home-Therapies.com and go to a third-party website. Fresenius Medical Care has no control over third-party websites; it is not responsible for and does not endorse the content of such websites or the business practices or policies of operators of such sites.

For our complete policy regarding links to third-party web sites, see our “Terms of Use”.

×